epigallocatechin gallate

signal transducer and activator of transcription 1 ; Homo sapiens







29 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34649540 STAT1: a novel candidate biomarker and potential therapeutic target of the recurrent aphthous stomatitis. 2021 Oct 14 2
2 34832863 EGCG Inhibits Tumor Growth in Melanoma by Targeting JAK-STAT Signaling and Its Downstream PD-L1/PD-L2-PD1 Axis in Tumors and Enhancing Cytotoxic T-Cell Responses. 2021 Oct 26 4
3 32708322 Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19? 2020 Jul 21 1
4 30126206 Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth. 2018 Aug 18 1
5 30558329 Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients. 2018 Dec 15 4
6 28703809 Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity. 2017 Jul 13 2
7 26345342 Epigallocatechin-3-gallate (EGCG) Suppresses the Trafficking of Lymphocytes to Epidermal Melanocytes via Inhibition of JAK2: Its Implication for Vitiligo Treatment. 2015 1
8 23676554 Effect of epigallocatechin-3-gallate on graft-versus-host disease. 2014 4
9 24038588 Quercetin and EGCG exhibit chemopreventive effects in cholangiocarcinoma cells via suppression of JAK/STAT signaling pathway. 2014 Jun 1
10 24255956 Direct interaction of natural and synthetic catechins with signal transducer activator of transcription 1 affects both its phosphorylation and activity. 2014 Feb 4
11 24728078 Increased STAT1 signaling in endocrine-resistant breast cancer. 2014 1
12 25261409 Epigallocatechin-3-gallate sensitizes IFN-γ-stimulated CD4+ T cells to apoptosis via alternative activation of STAT1. 2014 Dec 3
13 23158905 Flavanocoumarins from Guazuma ulmifolia bark and evaluation of their affinity for STAT1. 2013 Feb 2
14 22020144 Green tea EGCG, T cells, and T cell-mediated autoimmune diseases. 2012 Feb 1
15 22618201 NF-κΒ inhibition is ineffective in blocking cytokine-induced IL-8 production but P38 and STAT1 inhibitors are effective. 2012 Sep 1
16 23741252 (-)-Epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells. 2012 Sep 4
17 20812906 Use of STAT1 inhibitors in the treatment of brain I/R injury and neurodegenerative diseases. 2011 Mar 1 2
18 19928918 Indoleamine 2,3-dioxygenase, an immunomodulatory protein, is suppressed by (-)-epigallocatechin-3-gallate via blocking of gamma-interferon-induced JAK-PKC-delta-STAT1 signaling in human oral cancer cells. 2010 Jan 27 5
19 18678988 Selective up-regulation of P2X4-receptor gene expression by interferon-gamma in vascular endothelial cells. 2008 Aug 1
20 18784813 HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide. 2008 Jan 1 2
21 18850185 Protective effect of epigallocatechin-3-gallate on ischemia/reperfusion-induced injuries in the heart: STAT1 silencing flavonoid. 2007 Dec 5
22 15723092 Signaling of short- and long-term regulation of intestinal epithelial type 1 Na+/H+ exchanger by interferon-gamma. 2005 May 5
23 16174516 Interferon-gamma-induced STAT1-mediated membrane retention of NHE1 and associated proteins ezrin, radixin and moesin in HT-29 cells. 2005 Nov 1 5
24 15231486 Green tea polyphenol (-)-epigallocatechin gallate blocks epithelial barrier dysfunction provoked by IFN-gamma but not by IL-4. 2004 Nov 1
25 15277314 Intestinal Na+-K+-ATPase activity and molecular events downstream of interferon-gamma receptor stimulation. 2004 Aug 2
26 15319365 Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. 2004 Oct 1
27 15601580 Role of STAT-1 and STAT-3 in ischaemia/reperfusion injury. 2004 Oct-Dec 1
28 12485906 Antiinflammatory action of EGCG, the main component of green tea, through STAT-1 inhibition. 2002 Nov 1
29 11344123 Anti-interferon gamma action of epigallocatechin-3-gallate mediated by specific inhibition of STAT1 activation. 2001 May 1